UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 129

Sortiert nach

Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessment

Journal of experimental & clinical cancer research, 2022-12, Vol.41 (1), p.344-9, Article 344

2022

Volltextzugriff (PDF)

A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma

Clinical cancer research, 2019-10, Vol.25 (19), p.5799-5807

2019

Volltextzugriff (PDF)

Primary Brain Tumors: Introduction

Seminars in oncology, 2014-08, Vol.41 (4), p.437-437

2014

Volltextzugriff (PDF)

First-in-Human Clinical Trial of Oral ONC201 in Patients with Refractory Solid Tumors

Clinical cancer research, 2017-08, Vol.23 (15), p.4163-4169

2017

Volltextzugriff (PDF)

Results of a Pilot Study Involving the Use of an Antisense Oligodeoxynucleotide Directed Against the Insulin-Like Growth Factor Type I Receptor in Malignant Astrocytomas

Journal of clinical oncology, 2001-04, Vol.19 (8), p.2189-2200

2001

Volltextzugriff (PDF)

A 54‐Year‐Old Male with Multiple Intracranial and Extracranial Masses

Brain pathology (Zurich, Switzerland), 2017-09, Vol.27 (5), p.693-694

2017

Volltextzugriff (PDF)

Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme

Journal of neuro-oncology, 2012-11, Vol.110 (2), p.257-264

2012

Volltextzugriff (PDF)

Erratum to: Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme

Journal of neuro-oncology, 2013-05, Vol.113 (1), p.151-151

2013

Volltextzugriff (PDF)

Neurologic Complications of Head and Neck Cancers

Seminars in oncology, 2006-06, Vol.33 (3), p.348-351

Aiken, Robert D.

2006

Volltextzugriff (PDF)

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial

JAMA oncology, 2023-01, Vol.9 (1), p.112

2023

Volltextzugriff (PDF)

Final results of phase 2 trial of personal dendritic cell (DC) vaccines loaded with autologous tumor antigens (ATA) in newly diagnosed glioblastoma (GBM)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.2047-2047

2023

Volltextzugriff (PDF)

CTIM-33. PHASE II TRIAL OF VACCINE IMMUNOTHERAPY IN PRIMARY GLIOBLASTOMA: ADJUNCTIVE AUTOLOGOUS DENDRITIC CELLS PULSED WITH LYSATE FROM IRRADIATED SELF-RENEWING AUTOLOGOUS TUMOR CELLS (AV-GBM-1)

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi58-vi58

2021

Volltextzugriff (PDF)

Treatment of Brain Tumors

The New England journal of medicine, 2005-06, Vol.352 (22), p.2350-2353

2005

Volltextzugriff (PDF)

Abstract CT182: Adjunctive treatment of primary glioblastoma with patient-specific dendritic cell vaccines pulsed with antigens from self-renewing autologous tumor cells: A phase II trial

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.CT182-CT182

2020

Volltextzugriff (PDF)

Abstract CT571: Plasma proteomic markers prognostic or predictive for survival of patients with newly diagnosed glioblastoma who were treated in a phase II trial with standard care and the addition of the novel patient-specific dendritic cell vaccine AV-GBM-1

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.CT571-CT571

2022

Volltextzugriff (PDF)

Neurologic Complications of Systemic Cancer: Introduction

Seminars in oncology, 2006-06, Vol.33 (3), p.269-269

Aiken, Robert D.

2006

Volltextzugriff (PDF)

Neurologic complications of systemic cancer

Seminars in oncology, 2006, Vol.33 (3)

AIKEN, Robert D

2006

Volltextzugriff (PDF)

Neurologic complications of head and neck cancers: Neurologic complications of systemic cancer

Seminars in oncology, 2006, Vol.33 (3), p.348-351

AIKEN, Robert D

2006

Volltextzugriff (PDF)

Treatment of brain tumors

The New England journal of medicine, 2005-06, Vol.352 (22), p.2350

Aiken, Robert D

2005

Volltextzugriff (PDF)

Delayed cortical blindness and recurrent quadriplegia after cervical trauma

Journal of spinal disorders, 1998-12, Vol.11 (6), p.535

1998

Volltextzugriff (PDF)

Dissolved organic carbon and chromophoric dissolved organic matter properties of rivers in the USA

Journal of Geophysical Research: Biogeosciences, 2012-09, Vol.117 (G3), p.n/a

2012

Volltextzugriff (PDF)

Measurement of Dissolved Organic Matter Fluorescence in Aquatic Environments: An Interlaboratory Comparison

Environmental science & technology, 2010-12, Vol.44 (24), p.9405-9412

2010

Volltextzugriff (PDF)

Unifying Concepts Linking Dissolved Organic Matter Composition to Persistence in Aquatic Ecosystems

Environmental science & technology, 2018-03, Vol.52 (5), p.2538-2548

2018

Volltextzugriff (PDF)

A large, refractory nosocomial outbreak of Klebsiella pneumoniae carbapenemase-producing Escherichia coli demonstrates carbapenemase gene outbreaks involving sink sites require novel approaches to infection control

Antimicrobial agents and chemotherapy, 2018-12, Vol.62 (12)

2018

Volltextzugriff (PDF)

1 – 25 von 129

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(114)

Publikationsform

Sprache

Englisch
(128)
Japanisch
(20)

Erscheinungsjahr

n.n

Thema

Science & Technology
(85)
Life Sciences & Biomedicine
(68)
Humans
(34)
Male
(19)
Physical Sciences
(19)
Biological And Medical Sciences
(17)
Female
(17)
Oncology
(16)
Aged
(15)
Environmental Sciences
(15)
Environmental Sciences & Ecology
(14)
United States
(14)
Middle Aged
(13)
Exact Sciences And Technology
(11)
Fundamental And Applied Biological Sciences. Psychology
(11)
Adult
(10)
Aged, 80 And Over
(9)
Clinical Trials
(9)
Technology
(9)
Animals
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessment

A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma

Primary Brain Tumors: Introduction

First-in-Human Clinical Trial of Oral ONC201 in Patients with Refractory Solid Tumors

Results of a Pilot Study Involving the Use of an Antisense Oligodeoxynucleotide Directed Against the Insulin-Like Growth Factor Type I Receptor in Malignant Astrocytomas

A 54‐Year‐Old Male with Multiple Intracranial and Extracranial Masses

Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme

Erratum to: Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme

Neurologic Complications of Head and Neck Cancers

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial

Final results of phase 2 trial of personal dendritic cell (DC) vaccines loaded with autologous tumor antigens (ATA) in newly diagnosed glioblastoma (GBM)

CTIM-33. PHASE II TRIAL OF VACCINE IMMUNOTHERAPY IN PRIMARY GLIOBLASTOMA: ADJUNCTIVE AUTOLOGOUS DENDRITIC CELLS PULSED WITH LYSATE FROM IRRADIATED SELF-RENEWING AUTOLOGOUS TUMOR CELLS (AV-GBM-1)

Treatment of Brain Tumors

Abstract CT182: Adjunctive treatment of primary glioblastoma with patient-specific dendritic cell vaccines pulsed with antigens from self-renewing autologous tumor cells: A phase II trial

Abstract CT571: Plasma proteomic markers prognostic or predictive for survival of patients with newly diagnosed glioblastoma who were treated in a phase II trial with standard care and the addition of the novel patient-specific dendritic cell vaccine AV-GBM-1

Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration

Neurologic Complications of Systemic Cancer: Introduction

Neurologic complications of systemic cancer

Neurologic complications of head and neck cancers: Neurologic complications of systemic cancer

Treatment of brain tumors

Delayed cortical blindness and recurrent quadriplegia after cervical trauma

Dissolved organic carbon and chromophoric dissolved organic matter properties of rivers in the USA

Measurement of Dissolved Organic Matter Fluorescence in Aquatic Environments: An Interlaboratory Comparison

Unifying Concepts Linking Dissolved Organic Matter Composition to Persistence in Aquatic Ecosystems

A large, refractory nosocomial outbreak of Klebsiella pneumoniae carbapenemase-producing Escherichia coli demonstrates carbapenemase gene outbreaks involving sink sites require novel approaches to infection control

Suchergebnisse filtern